Gordon Meiklejohn
- Epidemiology top 2%
- Influenza Virus Research Studies 27
- Respiratory viral infections research 21
- Virology and Viral Diseases 4
- Infectious Diseases top 2%
- Viral gastroenteritis research and epidemiology 7
- Virology top 10%
- Poxvirus research and outbreaks 5
- Immunology top 10%
- Parasitology top 5%
-
- Diabetes and associated disorders 4
- Virus-based gene therapy research 3
-
- Monoclonal and Polyclonal Antibodies Research 4
Gordon Meiklejohn
50 papers receiving 1.4k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Epidemiology 1.2k
- Infectious Diseases 568
- Virology 78
- Immunology 258
- Parasitology 76
Countries citing papers authored by Gordon Meiklejohn
This map shows the geographic impact of Gordon Meiklejohn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gordon Meiklejohn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gordon Meiklejohn more than expected).
Fields of papers citing papers by Gordon Meiklejohn
This network shows the impact of papers produced by Gordon Meiklejohn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gordon Meiklejohn. The network helps show where Gordon Meiklejohn may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gordon Meiklejohn, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 101 | |
| 2 | INFLUENZA ACTIVITY - UNITED-STATES AND WORLDWIDE - COMPOSITION OF THE 1992-1993 INFLUENZA VACCINE (REPRINTED FROM MMWR, VOL 41, PG 315-323, 1992) | 1992 | 2 |
| 3 | 1991 | 24 | |
| 4 | 1991 | 103 | |
| 5 | 1989 | 34 | |
| 6 | 1989 | 32 | |
| 7 | 1988 | 36 | |
| 8 | 1985 | 14 | |
| 9 | 1982 | 13 | |
| 10 | 1980 | 9 | |
| 11 | 1977 | 7 | |
| 12 | 1973 | 3 | |
| 13 | Protection against Hong Kong influneza by adjuvant vaccine containing A2-Ann Arbor-67. | 1969 | 18 |
| 14 | 1962 | 20 | |
| 15 | Air sampling to recover variola virus in the environment of a smallpox hospital. | 1961 | 23 |
| 16 | Studies on the virus content of mouth washings in the acute phase of smallpox. | 1961 | 21 |
| 17 | 1960 | 10 | |
| 18 | 1958 | 9 | |
| 19 | 1952 | 26 | |
| 20 | 1952 | 2 |
About Gordon Meiklejohn
Gordon Meiklejohn is a scholar working on Epidemiology, Virology and Infectious Diseases, having authored 53 papers that have together received 1.6k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (27 papers), Respiratory viral infections research (21 papers), Viral gastroenteritis research and epidemiology (7 papers), Poxvirus research and outbreaks (5 papers), Virology and Viral Diseases (4 papers), Diabetes and associated disorders (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Epidemiology (1.2k citations), Infectious Diseases (568 citations) and Virology (78 citations). Gordon Meiklejohn has collaborated with scholars based in United States, Japan and Chile. Frequent co-authors include M Minamitani, Otto F. Sieber, Vincent A. Fulginiti, Jerry J. Eller, Theodore C. Eickhoff, Myron J. Levin, H Grant Stiver, Jessie R. Groothuis, Brian A. Lauer and Gerard P. Rabalais. Their work appears in journals such as New England Journal of Medicine, JAMA and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.